Skin lesions and vancomycin use in a hemodialysis patient

Vancomycin is a widely used antibiotic in hemodialysis patients. The main complications include renal toxicity and skin lesions. Herein, we report the case of a 29‐year‐old hemodialysis patient who presented a bullous pruriginous dermatosis after vancomycin treatment. A skin biopsy revealed a linear...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Hemodialysis international 2019-10, Vol.23 (4), p.E127-E129
Hauptverfasser:	Schurder, Juliet, Morel, Pauline, Blanc, Julie, Clerté, Maëva, Ridel, Christophe, Touzot, Maxime
Format:	Artikel
Sprache:	eng
Schlagworte:	dialysis skin toxicity vancomycin
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	E129
container_issue	4
container_start_page	E127
container_title	Hemodialysis international
container_volume	23
creator	Schurder, Juliet Morel, Pauline Blanc, Julie Clerté, Maëva Ridel, Christophe Touzot, Maxime
description	Vancomycin is a widely used antibiotic in hemodialysis patients. The main complications include renal toxicity and skin lesions. Herein, we report the case of a 29‐year‐old hemodialysis patient who presented a bullous pruriginous dermatosis after vancomycin treatment. A skin biopsy revealed a linear IgA bullous dermatosis (LABD). This is a rare form of dermatosis and is either idiopathic or more likely vancomycin‐induced. Similarities in the molecular structure of vancomycin and epidermal basement membrane glycoproteins could explain the auto‐immune response. The overall prognosis after drug discontinuation and dermocorticoid treatment was good.
doi_str_mv	10.1111/hdi.12786
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2300597679</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2300597679</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3256-5463cdec53ea87aec722797c43f6966279847743765b9d5263185103e2a8263d3</originalsourceid><addsrcrecordid>eNp1kLtOAzEQRS0EIiFQ8ANoSyg28dvrEoVHIkWiAGrLsSeKYR9hnQXt32NYoGOaOzM6usVB6JzgKUkz2_owJVQV8gCNieA050oUh2nnmuZKMDFCJzG-YEwJxvIYjRgRSmvNx0g_voY6KyGGpo6ZrX32bmvXVL1L7y5ClsJmW6gaH2zZxxCznd0HqPen6GhjywhnPzlBz3e3T_NFvnq4X86vV7ljVMhccMmcBycY2EJZcIpSpZXjbCO1lGkvuFKcKSnW2gsqGSkEwQyoLdLh2QRdDr27tnnrIO5NFaKDsrQ1NF00lGEstJJKJ_RqQF3bxNjCxuzaUNm2NwSbL1MmmTLfphJ78VPbrSvwf-SvmgTMBuAjlND_32QWN8uh8hPC4G_9</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2300597679</pqid></control><display><type>article</type><title>Skin lesions and vancomycin use in a hemodialysis patient</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Schurder, Juliet ; Morel, Pauline ; Blanc, Julie ; Clerté, Maëva ; Ridel, Christophe ; Touzot, Maxime</creator><creatorcontrib>Schurder, Juliet ; Morel, Pauline ; Blanc, Julie ; Clerté, Maëva ; Ridel, Christophe ; Touzot, Maxime</creatorcontrib><description>Vancomycin is a widely used antibiotic in hemodialysis patients. The main complications include renal toxicity and skin lesions. Herein, we report the case of a 29‐year‐old hemodialysis patient who presented a bullous pruriginous dermatosis after vancomycin treatment. A skin biopsy revealed a linear IgA bullous dermatosis (LABD). This is a rare form of dermatosis and is either idiopathic or more likely vancomycin‐induced. Similarities in the molecular structure of vancomycin and epidermal basement membrane glycoproteins could explain the auto‐immune response. The overall prognosis after drug discontinuation and dermocorticoid treatment was good.</description><identifier>ISSN: 1492-7535</identifier><identifier>EISSN: 1542-4758</identifier><identifier>DOI: 10.1111/hdi.12786</identifier><identifier>PMID: 31579994</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley & Sons, Inc</publisher><subject>dialysis ; skin ; toxicity ; vancomycin</subject><ispartof>Hemodialysis international, 2019-10, Vol.23 (4), p.E127-E129</ispartof><rights>2019 International Society for Hemodialysis</rights><rights>2019 International Society for Hemodialysis.</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3256-5463cdec53ea87aec722797c43f6966279847743765b9d5263185103e2a8263d3</citedby><cites>FETCH-LOGICAL-c3256-5463cdec53ea87aec722797c43f6966279847743765b9d5263185103e2a8263d3</cites><orcidid>0000-0002-0510-2431</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fhdi.12786$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fhdi.12786$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31579994$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schurder, Juliet</creatorcontrib><creatorcontrib>Morel, Pauline</creatorcontrib><creatorcontrib>Blanc, Julie</creatorcontrib><creatorcontrib>Clerté, Maëva</creatorcontrib><creatorcontrib>Ridel, Christophe</creatorcontrib><creatorcontrib>Touzot, Maxime</creatorcontrib><title>Skin lesions and vancomycin use in a hemodialysis patient</title><title>Hemodialysis international</title><addtitle>Hemodial Int</addtitle><description>Vancomycin is a widely used antibiotic in hemodialysis patients. The main complications include renal toxicity and skin lesions. Herein, we report the case of a 29‐year‐old hemodialysis patient who presented a bullous pruriginous dermatosis after vancomycin treatment. A skin biopsy revealed a linear IgA bullous dermatosis (LABD). This is a rare form of dermatosis and is either idiopathic or more likely vancomycin‐induced. Similarities in the molecular structure of vancomycin and epidermal basement membrane glycoproteins could explain the auto‐immune response. The overall prognosis after drug discontinuation and dermocorticoid treatment was good.</description><subject>dialysis</subject><subject>skin</subject><subject>toxicity</subject><subject>vancomycin</subject><issn>1492-7535</issn><issn>1542-4758</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp1kLtOAzEQRS0EIiFQ8ANoSyg28dvrEoVHIkWiAGrLsSeKYR9hnQXt32NYoGOaOzM6usVB6JzgKUkz2_owJVQV8gCNieA050oUh2nnmuZKMDFCJzG-YEwJxvIYjRgRSmvNx0g_voY6KyGGpo6ZrX32bmvXVL1L7y5ClsJmW6gaH2zZxxCznd0HqPen6GhjywhnPzlBz3e3T_NFvnq4X86vV7ljVMhccMmcBycY2EJZcIpSpZXjbCO1lGkvuFKcKSnW2gsqGSkEwQyoLdLh2QRdDr27tnnrIO5NFaKDsrQ1NF00lGEstJJKJ_RqQF3bxNjCxuzaUNm2NwSbL1MmmTLfphJ78VPbrSvwf-SvmgTMBuAjlND_32QWN8uh8hPC4G_9</recordid><startdate>201910</startdate><enddate>201910</enddate><creator>Schurder, Juliet</creator><creator>Morel, Pauline</creator><creator>Blanc, Julie</creator><creator>Clerté, Maëva</creator><creator>Ridel, Christophe</creator><creator>Touzot, Maxime</creator><general>John Wiley & Sons, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0510-2431</orcidid></search><sort><creationdate>201910</creationdate><title>Skin lesions and vancomycin use in a hemodialysis patient</title><author>Schurder, Juliet ; Morel, Pauline ; Blanc, Julie ; Clerté, Maëva ; Ridel, Christophe ; Touzot, Maxime</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3256-5463cdec53ea87aec722797c43f6966279847743765b9d5263185103e2a8263d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>dialysis</topic><topic>skin</topic><topic>toxicity</topic><topic>vancomycin</topic><toplevel>online_resources</toplevel><creatorcontrib>Schurder, Juliet</creatorcontrib><creatorcontrib>Morel, Pauline</creatorcontrib><creatorcontrib>Blanc, Julie</creatorcontrib><creatorcontrib>Clerté, Maëva</creatorcontrib><creatorcontrib>Ridel, Christophe</creatorcontrib><creatorcontrib>Touzot, Maxime</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Hemodialysis international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schurder, Juliet</au><au>Morel, Pauline</au><au>Blanc, Julie</au><au>Clerté, Maëva</au><au>Ridel, Christophe</au><au>Touzot, Maxime</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Skin lesions and vancomycin use in a hemodialysis patient</atitle><jtitle>Hemodialysis international</jtitle><addtitle>Hemodial Int</addtitle><date>2019-10</date><risdate>2019</risdate><volume>23</volume><issue>4</issue><spage>E127</spage><epage>E129</epage><pages>E127-E129</pages><issn>1492-7535</issn><eissn>1542-4758</eissn><abstract>Vancomycin is a widely used antibiotic in hemodialysis patients. The main complications include renal toxicity and skin lesions. Herein, we report the case of a 29‐year‐old hemodialysis patient who presented a bullous pruriginous dermatosis after vancomycin treatment. A skin biopsy revealed a linear IgA bullous dermatosis (LABD). This is a rare form of dermatosis and is either idiopathic or more likely vancomycin‐induced. Similarities in the molecular structure of vancomycin and epidermal basement membrane glycoproteins could explain the auto‐immune response. The overall prognosis after drug discontinuation and dermocorticoid treatment was good.</abstract><cop>Hoboken, USA</cop><pub>John Wiley & Sons, Inc</pub><pmid>31579994</pmid><doi>10.1111/hdi.12786</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-0510-2431</orcidid></addata></record>
fulltext	fulltext
identifier	ISSN: 1492-7535
ispartof	Hemodialysis international, 2019-10, Vol.23 (4), p.E127-E129
issn	1492-7535 1542-4758
language	eng
recordid	cdi_proquest_miscellaneous_2300597679
source	Wiley Online Library Journals Frontfile Complete
subjects	dialysis skin toxicity vancomycin
title	Skin lesions and vancomycin use in a hemodialysis patient
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T01%3A56%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Skin%20lesions%20and%20vancomycin%20use%20in%20a%20hemodialysis%20patient&rft.jtitle=Hemodialysis%20international&rft.au=Schurder,%20Juliet&rft.date=2019-10&rft.volume=23&rft.issue=4&rft.spage=E127&rft.epage=E129&rft.pages=E127-E129&rft.issn=1492-7535&rft.eissn=1542-4758&rft_id=info:doi/10.1111/hdi.12786&rft_dat=%3Cproquest_cross%3E2300597679%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2300597679&rft_id=info:pmid/31579994&rfr_iscdi=true